سعر اتروفنت 250مكجم/2مل 20 فيال جلسات البخار 2026

Atrovent 250 micrograms/2 ml nebuliser solution (ipratropium bromide) in single-dose vials, pack of 20, by Boehringer Ingelheim; an inhaled short-acting antimuscarinic bronchodilator for use with a nebuliser in COPD and asthma.

• Prevention and treatment of breathlessness (dyspnoea) in chronic obstructive pulmonary disease (COPD)Population: AdultsFachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• Mild to moderate bronchial asthma in adults and children, as an adjunct to beta2-agonists in acute asthma attacksPopulation: Adults and childrenFachinfo-Service (Rote Liste Service GmbH, fachinfo.de)

• Common: headache, dizziness, cough, throat irritation, dry mouth, taste disturbance, gastrointestinal motility disorders, nausea.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• Uncommon: anaphylactic/hypersensitivity reactions; blurred vision, mydriasis, raised intraocular pressure, eye pain, halos, conjunctival hyperaemia, corneal oedema, glaucoma; palpitations, supraventricular tachycardia; (paradoxical) bronchospasm, laryngospasm, pharyngeal oedema, dry throat; constipation, diarrhoea, vomiting, stomatitis, mouth oedema; rash, pruritus, angioedema; urinary retention.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• Rare: accommodation disorders, atrial fibrillation, urticaria.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)

• Hypersensitivity to ipratropium bromide, atropine or other atropine derivatives, or to any excipient.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)

• Immediate hypersensitivity reactions may occur (rare cases of rash, urticaria, angioedema, oropharyngeal oedema, bronchospasm and anaphylaxis).International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• Paradoxical bronchospasm, which may be life-threatening, can occur; stop treatment immediately and switch to an alternative.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• Ocular complications: prevent the solution or mist from entering the eyes (use a mouthpiece rather than a face mask); caution in patients predisposed to narrow-angle glaucoma, in whom acute angle-closure glaucoma (eye pain, blurred vision, halos, red eyes, corneal oedema) may be precipitated. Mydriasis and mild accommodation disturbances can be treated with miotic eye drops; seek an ophthalmologist for severe eye complications.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)

• Other anticholinergic medicines (e.g. pirenzepine)Chronic co-administration with other anticholinergics has not been studied and is not recommended; other anticholinergics may increase effects and side effects.Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• Beta-adrenergic agonists and xanthine derivatives (e.g. theophylline)May enhance the bronchodilator effect.Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• Beta2-agonists (in patients with narrow-angle glaucoma)Combined nebulised use may increase the risk of acute angle-closure glaucoma in patients with a history of narrow-angle glaucoma.Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)

• No human experience in pregnancy. Although no fetotoxic effects are known, use in pregnancy, particularly in the first trimester, only if the physician considers it necessary after careful benefit-risk assessment, taking into account the risks of inadequate treatment. Non-clinical data suggest ipratropium does not cross the placenta; no malformations were seen in animal reproduction studies.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)
• No human experience during breastfeeding; use only if the physician considers it necessary after careful benefit-risk assessment.International label, same product · Fachinfo-Service (Rote Liste Service GmbH, fachinfo.de)

• Ipratropium bromide: Blocks muscarinic receptors in bronchial smooth muscle, reducing vagally mediated bronchoconstriction; minimal systemic absorption when inhaled.